CD133 expression predicts for non-response to chemotherapy in colorectal cancer
10.1038/modpathol.2009.181
Saved in:
Main Authors: | Ong, C.W., Kim, L.G., Soong, R., Salto-Tellez, M., Kong, H.H., Low, L.Y., Iacopetta, B. |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
2012
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/33132 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical significance of cancer stem cell markers and other related proteins in colorectal carcinomas - Biological and methodological considerations
by: ONG CHEE WEE
Published: (2011) -
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
by: Soong, R., et al.
Published: (2012) -
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
by: Soong, R., et al.
Published: (2011) -
Proteomic analysis of colorectal cancer metastasis: Stathmin-1 revealed as a player in cancer cell migration and prognostic marker
by: Tan, H.T., et al.
Published: (2014) -
Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair
by: Rufaihah, A.J., et al.
Published: (2014)